Abstract
Objective: To inform a research plan for future studies by obtaining stakeholder input on the application of preference-based methods to clinical trial design. Methods: We conducted a virtual OMERACT session to encourage stakeholder engagement. We developed materials for the session to facilitate discussion based on identified case examples and feedback sessions. Results: Participants prioritized incorporating patient preferences in all aspects of trial design with an empha-sis on outcome selection. Participants highlighted the need for careful consideration around preference het-erogeneity and equity factors. Conclusion: Including patient preferences in trial design was considered a priority requiring further explora-tion to develop comprehensive guidance. (c) 2021 Elsevier Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 919-924 |
Number of pages | 6 |
Journal | Seminars in Arthritis and Rheumatism |
Volume | 51 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Aug 2021 |
Keywords
- OMERACT
- Patient preferences
- Preference-based methods
- Rheumatology
- Clinical trials
- Trade-offs